搜尋結果
Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly
CNBC· 7 小時前In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson ...
The Images That Boost Support for Sustainable Transportation
Bloomberg· 14 小時前AI-generated illustrations of streets with bike lanes, bus lanes and fewer cars have the power ...
Wall Street analyst jumps to Disney's defense — plus, why Broadcom is bucking the chip ...
CNBC· 2 日前Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable ...
The streets won't forget: Why Newcastle cult hero Hatem Ben Arfa never returned on his ...
Goal.com· 5 日前Ever since his rise to stardom at Lyon, Hatem Ben Arfa has generated headlines around the world ...
Storm-battered South is again under threat. A boy swept into a drain fights for his life
Bastillepost· 1 日前Dangerous storms crashed over parts of the South on Thursday even as the region cleaned up from ...
Opinion | Whose Trade War Is Worse, Trump’s or Biden’s?
The Wall Street Journal· 10 小時前Holman W. Jenkins Jr. is a member of the editorial board of The Wall Street Journal. Mr. Jenkin ...
Sweetgreen shares soar 34% after company beats revenue expectations
CNBC· 13 小時前Sweetgreen shares surged nearly 34% on Friday after the company topped Wall Street's revenu ...
Opinion | 2024 Election: A Certain Fatalism Sets In
The Wall Street Journal· 1 日前Peggy Noonan is an opinion columnist at the Wall Street Journal where her column, "Declara ...
Wall Street Loves Lunch Stocks: Why These Fast Casual Chains Are Outperforming Nvidia
Forbes· 1 日前Lunch is the most important meal of the day for investors in 2024 as shares of fast casual ...
Wall Street bonuses to rise this year as deals return, says report
Reuters· 4 日前Bonuses are poised to recover on Wall Street this year, fueled by strong equity market gains ...